Spinal cord injury (SCI) is a devastating and irreversible damage to the central nervous system that can result in permanent disability or even death. Electrospinning technology, as a specialized fiber preparation method, possesses unique advantages such as high porosity, adjustable pore size, and an extremely high surface area-to-volume ratio. Despite the widespread attention this technology has garnered for its potential application in the treatment of SCI, there is still a lack of comprehensive and up-to-date reviews in the existing literature, and specific clinical treatment guidelines are also scarce. As a result, researchers and clinicians lack targeted guidance for practical implementation. To address this gap, the present article systematically summarizes the mechanisms by which electrospun scaffolds facilitate SCI repair and their current therapeutic applications. First, this review provides an in-depth analysis of the five core mechanisms underlying electrospinning therapy for SCI, including extracellular matrix (ECM) mimicry, axonal-extension guidance, multimodal signal regulation, drug loading and sustained release, and physical support and protection. Next, this review examines how key electrospinning parameters (fiber diameter, alignment, surface chemistry, biodegradation rate, and nanomorphology) influence these therapeutic mechanisms. Finally, this review explores the state-of-the-art applications of electrospun scaffolds in SCI treatment, including purely structural conduits, biochemical functionalization (drug loading and controlled release, immunomodulation and anti-inflammation, and coaxial electrospinning), and multi-component composite materials (hydrogel–electrospun hybrids, cell- and growth-factor co-delivery systems, and cell electrospinning).
Yang et al. (Thu,) studied this question.